Document:

EX-4.3

 Exhibit 4.3 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, OR TRANSFERRED EXCEPT IN COMPLIANCE THEREWITH. 
 THE SECURITIES ISSUABLE UPON EXERCISE HEREOF ARE ALSO
SUBJECT TO ADDITIONAL RESTRICTIONS, INCLUDING RESTRICTIONS ON TRANSFER, AS SET FORTH IN A STOCKHOLDERS AGREEMENT, A COPY OF WHICH WILL BE FURNISHED BY TV2 HOLDING COMPANY UPON REQUEST AND WITHOUT CHARGE. 

WARRANT TO PURCHASE SHARES OF COMMON STOCK 

Issue Date: October 30, 2012 

FOR VALUE RECEIVED, TV2 Holding Company, a Delaware corporation (the
“Company”), certifies that Capital Royalty Partners II L.P. (the “Holder”), is entitled, subject to the terms and conditions hereof, to purchase from the Company up to
[                ] shares of Common Stock of the Company (such shares, the “Warrant Shares”), at a price per share equal to $0.01 (the
“Exercise Price”). By acceptance of this warrant (the “Warrant”), Holder agrees to all the terms and conditions hereof. 

1. Exercise Period. This Warrant may be exercised at any time during the period (the “Exercise Period”)
commencing on the date hereof and ending on the 10th anniversary thereof, unless sooner terminated in accordance with the provisions hereof. 

2. Method of Exercise. This Warrant may be exercised in whole or in part by delivery of the following to the Company at its address set
forth on the signature page hereto (or at such other address as it may designate by notice in writing to Holder): (i) an executed Notice of Exercise in the form attached hereto as Exhibit A; (ii) payment in United States dollars by check
or wire transfer in readily available funds of the aggregate exercise price of the Warrant Shares to be purchased (unless exercised pursuant to Section 3 hereof); and (iii) this Warrant. 

3. Net Exercise. Notwithstanding the foregoing, if on the date of exercise of this Warrant the fair market value of one Warrant Share
(as determined in good faith by the Board of Directors) exceeds the Exercise Price, then in lieu of payment in cash or by check for the Warrant Shares to be purchased, Holder may elect to receive that number of Warrant Shares as is determined using
the following formula: 
  

			
	X =	 	Y * (A – B)
		 	        A

  

			
	where:	  	X = the number of Warrant Shares to be issued to Holder;
		
		  	Y = the number of Warrant Shares with respect to which Holder is exercising its purchase right under this Warrant;
		
		  	A = the fair market value of one Warrant Share on the date of exercise; and
		
		  	B = the Exercise Price

 4. Rights Upon Exercise. All shares issued upon exercise of this Warrant shall be validly issued,
fully paid and non-assessable, shall be free from all taxes, liens, and charges with respect to the issuance thereof (other than any encumbrances created by or imposed upon Holder), and shall have the

 
same rights, preferences and privileges, and be subject to the same restrictions, as the Common Stock generally. Holder acknowledges and agrees that, upon exercise of this Warrant, Holder shall
be required to execute and deliver a joinder to the Company’s Third Amended and Restated Stockholders Agreement, as the same may be amended from time to time (the “Stockholders’ Agreement”) and such other documents
(including by way of illustration and without limitation, stock purchase, investor rights, voting and/or co-sale agreements) as may be required to grant Holder the same rights, and subject Holder to the same duties and obligations, as Holders of
Common Stock generally. 
 5. Securities Laws. Notwithstanding anything herein to the contrary, the Company’s obligation to
issue shares of stock to Holder pursuant hereto is expressly conditioned on compliance of such issuance with applicable federal and state securities laws, without registration or qualification thereunder. 

6. No Fractional Shares; Share Certificates. No fractional shares shall be issued upon exercise of this Warrant. If upon exercise of
this Warrant a fractional share results, the Company shall pay Holder the cash value of that fractional share based on the Exercise Price. The certificates representing any shares purchased upon exercise of this Warrant shall be delivered to Holder
as soon as practicable after surrender of this Warrant to the Company. 
 7. Adjustment of Exercise Price and Number of Shares. In
the event of any change in the outstanding Common Stock by reason of a stock dividend, stock split, recapitalization, reclassification, combination or exchange of shares, separation, reorganization, liquidation or the like (each, an
“Adjustment Event”), the securities purchasable upon exercise of this Warrant and the Exercise Price shall be correspondingly adjusted to give Holder, upon exercise of this Warrant for the same aggregate Exercise Price, the
aggregate number, class and kind of shares or other securities that Holder would have owned had Holder exercised the Warrant prior to such Adjustment Event and continued to hold the shares so received until after such Adjustment Event. Any
adjustment pursuant to this Section 7 shall become effective at the close of business on the effective date of such Adjustment Event; provided, however, that if a record date is fixed for such Adjustment Event, then the effective date of
such adjustment shall be such record date. The form of this Warrant need not be changed because of any adjustment pursuant to this Section 7. 

8. Automatic Exercise. At any time during the Exercise Period, in the event of any Liquidation Event (as defined in the Certificate of
Incorporation of the Company, as amended (the “Charter”) but excluding clause (i) of such definition), this Warrant shall be deemed automatically exercised in whole pursuant to the formula and procedures set forth in
Section 3 hereof. 
 9. Representations and Warranties of Holder. 

a. Accredited Investor; Preexisting Relationship. Holder is an “accredited investor” within the meaning of Rule 501(a) under
the Securities Act of 1933, as amended and as presently in effect (the “Securities Act”). Holder was not formed for the specific purpose of acquiring this Warrant and the Warrant Shares (collectively, the
“Securities”). Holder either (i) has a preexisting personal or business relationship with the Company or one of its directors, officers or controlling persons; or (ii) has the capacity to protect Holder’s own
interest in connection with the transactions contemplated hereby by reason of Holder’s business or financial experience or the business or financial experience of Holder’s professional advisers who are unaffiliated with and who are not
compensated by the Company of any affiliate thereof, directly or indirectly. 
 b. Purchase for Own Account. Holder is acquiring the
Securities for Holder’s own account for investment purposes, not as a nominee or agent, and not with a view to the sale or 

  
 -2- 

 
distribution of any part thereof. Holder has no present intention of selling, transferring, granting any participation in, or otherwise distributing any of the Securities, and Holder presently
has no reason to anticipate a change in such intention. Holder has no contract, agreement, undertaking or arrangement with any person to sell, transfer, grant participation in or otherwise distribute any of the Securities. Holder understands that
Company is issuing this Warrant in reliance upon Holder’s representations in this Section 9. 
 c. Investment Experience.
Holder acknowledges that investment in the Securities involves a high degree of risk. Holder has such knowledge and experience in financial and business matters that Holder is capable of evaluating the merits and risks of Holder’s investment in
the Securities and of protecting Holder’s own interests in connection with the transactions contemplated hereby. Holder is able, without materially impairing Holder’s financial condition, to hold the Securities for an indefinite period of
time and to suffer a complete loss of Holder’s investment in the Securities. 
 d. Disclosure of Information. Holder has
received all the information that Holder has requested from the Company and that Holder considers necessary or appropriate for deciding whether to acquire the Securities. Holder has had an opportunity to ask questions and receive answers from the
Company regarding the terms and conditions of the offering of the Securities and to obtain any additional information from the Company necessary to verify the accuracy of the information given to Holder. 

e. No Public Market. Holder understands that the Securities have not been registered under the Securities Act and, therefore, the
Securities cannot be resold unless they are registered under the Securities Act or an exemption from registration is available. Holder understands that the Company is under no obligation to register any of the Securities. Holder understands that no
public market now exists for the Securities, and that it is uncertain whether such a public market will ever exist. 
 f. Restricted
Securities. Holder understands that the Securities are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving any public offering, and that under
such laws and applicable regulations such securities may be resold without registration under the Securities Act only in certain limited circumstances. Holder represents that Holder is familiar with Rule 144 under the Securities Act and understands
the resale limitations imposed thereby and by the Securities Act. 
 g. No General Solicitation. Neither Holder nor any of
Holder’s officers, directors, employees, agents, stockholders or partners has, either directly or indirectly, including through a broker or finder, engaged in any general solicitation or advertising in connection with the offer and sale of the
Securities, nor is Holder aware of any such general solicitation or advertising by the Company or any other party. 
 h. Authority;
Binding Obligation. Holder has full power and authority to enter into this Warrant, which, when executed and delivered by Holder, shall constitute a valid and legally binding obligation of Holder, enforceable in accordance with its terms, except
as limited by (i) laws of general application relating to bankruptcy, insolvency and the relief of debtors, (ii) rules of law governing specific performance, injunctive relief or other equitable remedies and by general principles of
equity, and (iii) with respect to waivers and rights to indemnity, applicable laws and principles of public policy. 
 i.
Location. The principal place of business of Holder is correctly set forth on the signature page hereof or an exhibit hereto. 

  
 -3- 

 10. Transfer Restrictions. Without limiting Holder’s representations in
Section 9 hereof, Holder agrees not to make any sale, transfer, pledge or other disposition of all or any portion of the Securities, or any beneficial interest therein, unless and until: 

a. There is then in effect a registration statement under the Securities Act covering the proposed disposition and such disposition is made in
accordance with such registration statement; or 
 b. The transferee is a “Permitted Transferee” (as such term is defined in the
Stockholders’ Agreement) and has agreed in writing to be bound by the terms of this Warrant and the Stockholders’ Agreement, and Holder has notified the Company of the proposed disposition, including a detailed statement of the
circumstances surrounding the proposed disposition, and if reasonably requested by the Company, has furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of the
Securities being transferred under the Securities Act. 
 11. No Stockholder Rights. Nothing contained herein shall be construed as
conferring upon Holder or any other person any rights, preferences or privileges as a stockholder of the Company, until and only to the extent that this Warrant is exercised for equity securities of the Company. 

12. Governing Law. This Warrant and the rights and obligations of the parties hereunder shall be governed by and construed under the
laws of the State of California, without regard to its choice of law or conflicts of law provisions. 
 13. Attorneys’ Fees. In
any legal proceeding arising out of or related to this Warrant, the prevailing party shall be entitled to reasonable attorneys’ fees and out-of-pocket costs, in addition to any other relief to which such party may be entitled. 

14. Entire Agreement. This Warrant and any documents delivered pursuant hereto (including the Stockholders’ Agreement),
constitutes the full and complete understanding and agreement of the parties with respect to the subject matter hereof, and supersedes any prior agreements between the parties with respect thereto. 

15. Severability. If any provision hereof is held unenforceable in any respect, such provision shall be invalid only to the extent of
such unenforceability, without invalidating the remainder of such provision or any other provision of this Warrant. 
 16. No Implied
Waiver. No failure to exercise, delay in exercising or partial exercise of any right or remedy hereunder shall operate as a waiver of any provision of this Warrant. No waiver of any provision of this Warrant shall operate as a waiver of any
other provision (whether or not similar), nor shall it operate as a continuing waiver, unless so provided in writing by the waiving party. 

17. Remedies Cumulative. All remedies afforded to any party hereto, either under this Warrant or by law or otherwise, shall be
cumulative and not alternative. 
 18. Counterparts. This Warrant may be executed in one or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute a single instrument. Facsimile signatures hereto shall be valid. 
 19.
Headings. The headings used in this Warrant are for convenience only and are not to be considered in construing this Warrant. 

  
 -4- 

 20. Amendment; Waiver. This Warrant may be modified, amended or terminated, and any
provision hereof waived, either generally or in a particular instance and either retroactively or prospectively, only by the written consent of the Company and the Holder, provided, however, that any party may by written consent waive
performance of any obligation owing to it hereunder, or agree to accept alternatives to such performance, without the consent of any other party. 

21. Assignment. Neither party may voluntarily or by operation of law assign this Warrant or any rights or obligations hereunder without
the prior written consent of the other party. Any attempted assignment in violation of this provision shall be null and void. 
 22.
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Warrant, and any consents or stipulations hereunder, shall inure to the benefit of and be binding upon the respective successors and assigns of each
party. 
 23. Third Party Beneficiaries. Except as otherwise provided herein, nothing in this Warrant, express or implied, is
intended to confer upon any third party any rights, remedies, obligations or liabilities. 
 24. Notices. Any notice, request,
communication or other document required or permitted to be given or delivered to the Holder or the Company shall be delivered, or shall be sent by certified or registered mail, postage prepaid, nationally recognized overnight courier, by prepaid
facsimile or electronic mail (in each case upon customary confirmation of receipt), or delivered personally to the Holder at its address as shown on the books of the Company or to the Company at the address indicated therefor on the signature page
of this Warrant. 
 25. Further Assurances. Each party agrees to execute and deliver such other documents and to take such other
actions as may reasonably be necessary to give full effect to the purposes of this Warrant and the terms and conditions hereof. 

[Remainder of this page intentionally left blank] 

  
 -5- 

 IN WITNESS WHEREOF, the
parties hereto have executed this Warrant as of the date first written above. 
  

					
	COMPANY
	
	TV2 HOLDING COMPANY
		
	By	 	  

		 	Name:	 	Michael Kramer
		 	Title:	 	Chief Financial Officer

  

					
	Address for Notices:
	3910 Brickway Blvd, Santa Rosa, CA 95403
		
	Attn:	 	Michael Kramer, Chief Financial Officer
	Tel.:	 	707.543.8709
	Fax:	 	707.541.3909
	Email:	 	mkramer@trivascular.com

  

									
	HOLDER
	
	CAPITAL ROYALTY PARTNERS II L.P.
		 	By	 	CAPITAL ROYALTY PARTNERS II GP L.P., its General Partner
		 		 	By	 	CAPITAL ROYALTY PARTNERS II GP LLC, its General Partner
				
		 		 	By	 	  

		 		 		 	Name:	 	Charles Tate
		 		 		 	Title:	 	Sole Member

  

			
	Address for Notices:
	1000 Main Street, Suite 2500
	Houston, TX 77002
	Attn:	 	General Counsel
	Tel.:	 	713.209.7350
	Fax:	 	713.209.7351
	Email:	 	adorenbaum@capitalroyalty.com

 [Signature Page to Warrant] 

 EXHIBIT A 

NOTICE OF EXERCISE 
  

			
	To:	  	TV2 Holding Company (the “Company”)
		
	Attention:	  	Chief Executive Officer

 The undersigned, holder of the attached Warrant (the “Warrant”), hereby elects to purchase
                 shares of Common Stock (the “Shares”) of the Company. 

The undersigned (check one): 
  

	 	 ̈	Tenders herewith payment of the aggregate exercise price of the Shares, together with any applicable transfer taxes thereon. 

  

	 	 ̈	Elects to purchase the Shares pursuant to the net exercise provision of the Warrant, and shall tender payment of any applicable transfer taxes thereon. 

Please issue a certificate or certificates representing said Shares in the name of the undersigned. 

The undersigned represents and warrants as follows: 

(i) The undersigned is acquiring the Shares for the undersigned’s own account for investment purposes, not as a nominee or agent, and not
with a view to the sale or distribution of any part thereof. The undersigned has no present intention of selling, transferring, granting any participation in, or otherwise distributing any of the Shares, and does not presently have reason to
anticipate a change in such intention. The undersigned has no contract, agreement, undertaking or arrangement with any person to sell, transfer, grant participation in or otherwise distribute any of the Shares. The undersigned understands that the
Company is issuing the Shares in reliance upon the undersigned’s representations herein. 
 (ii) The undersigned has received all the
information that it has requested from the Company and that it considers necessary or appropriate for deciding whether to acquire the Shares. The undersigned has had an opportunity to ask questions and receive answers from the Company regarding the
terms and conditions of the offering of the Shares and to obtain any additional information from the Company necessary to verify the accuracy of the information given to the undersigned. 

(iii) The undersigned acknowledges that investment in the Shares involves a high degree of risk. The undersigned has such knowledge and
experience in financial and business matters that it is capable of evaluating the merits and risks of its investment in the Shares and of protecting its own interests in connection with this transaction. The undersigned is able, without materially
impairing its financial condition, to hold the Shares for an indefinite period of time and to suffer a complete loss of its investment in the Shares. The undersigned is an “accredited investor” within the meaning of Rule 501(a) under the
Securities Act of 1933, as amended and as presently in effect (the “Securities Act”). 
 (iv) The undersigned
understands that the Shares have not been registered under the Securities Act and, therefore, the Shares cannot be resold unless they are registered under the Securities Act or an 

 
exemption from registration is available. The undersigned understands that the Company is under no obligation to register any of the Shares. The undersigned understands that no public market now
exists for the Shares, and that it is uncertain whether such a public market will ever exist. 
 (v) The undersigned understands that the
Shares are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving any public offering, and that under such laws and applicable regulations such
securities may be resold without registration under the Securities Act only in certain limited circumstances. The undersigned is familiar with Rule 144 under the Securities Act, and understands the resale limitations imposed thereby and by the
Securities Act. 
 (vi) The undersigned agrees not to make any disposition of all or any part of the aforesaid Shares unless and until there
is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration statement, or there is an exemption available under the Securities Act and, if
requested by the Company, the undersigned has provided the Company with an opinion of counsel satisfactory to the Company, stating that such registration is not required. 

(vii) If any registration of Common Stock shall be effected in connection with an underwritten public offering, the undersigned shall not
effect any public sale or distribution, including any sale pursuant to Rule 144, of any Shares or other security of the Company (except as part of such public offering) during the period beginning 14 days prior to the effective date of the
applicable registration statement until the earlier of (i) such time as the Company and the lead managing underwriter shall agree and (ii) 180 calendar days (such period, the “Lock-Up Period” for the applicable
registration statement); provided, however, that such 180-day period may be extended for up to 18 days to permit compliance with FINRA Rule 2711(f)(4) upon the request of any managing underwriter. The Company may impose stop-transfer
instructions with respect to securities subject to the foregoing restriction until the end of the applicable market standoff period. The undersigned agrees to execute a market standoff agreement with such underwriters in customary form consistent
with the provisions hereof. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all stockholders of the Company subject to such agreements, based on
the number of shares subject to such agreements. 
  

			
	Holder:	 	  

		
	By:	 	  

		
	Name:	 	  

		
	Its:	 	  

		
	Address:	 	  

		
	Address:	 	  

		
	Date:EX-4.4

 Exhibit 4.4 

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT
(i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE
APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 8 OF THIS WARRANT. 
 TV2 HOLDING
COMPANY 
 WARRANT TO PURCHASE COMMON STOCK 

For value received and subject to the provisions set forth in this warrant (this “Warrant”), [Entity affiliated
with Pinnacle Ventures] and its assigns are entitled to purchase from TV2 HOLDING COMPANY, a Delaware corporation (the “Company”): 
  

			
	Shares of Common Stock:	  	[                ]
		
	Exercise Price:	  	$0.31
		
	Term of Warrant:	  	10 years from the Warrant Date (subject to the limitations of Section 2 hereof)
		
	Warrant Date:	  	June 30, 2010

 The number of Shares for which this Warrant is exercisable and the Exercise Price may be adjusted as specified in
Section 5. 
 1. Definitions. As used herein, capitalized terms not otherwise defined herein shall have the meanings set
forth in the introductory paragraph of this Warrant or the following meanings: 
 (a) “Applicable Stock” means
(i) the Company’s presently authorized stock specified in the introductory paragraph of this Warrant, and (ii) upon any conversion, exchange, reclassification or change, any security into which the securities described in clauses
(i) or (ii) of this definition may be converted, exchanged, reclassified or otherwise changed. 
 (b) “Common
Stock” means the common stock of the Company. 
 (c) “Exercise Price” means the exercise price per
share of Applicable Stock specified in the introductory paragraph of this Warrant. 
 (d) “Holder” means the initial
holder of this Warrant set forth in the first paragraph of this Warrant and any other person or entity which becomes a holder of this Warrant pursuant to the terms of this Warrant. 

(e) “Loan Agreement” means that certain Loan and Security Agreement of even date herewith entered into by and among
the Company, TriVascular, Inc. (collectively with the Company, the 

 
“Borrowers”) and certain affiliates of the Holder pursuant to which the Company may, subject to the terms and conditions of the Loan Agreement, obtain Advances (as such
term is defined in the Loan Agreement) of up to $15,000,000. 
 (f) “Shares” means the shares of Applicable Stock of
Company issuable upon exercise of this Warrant. 
 (g) “Warrant Date” means the date of this Warrant specified in
the introductory paragraph of this Warrant. 
 (h) “Warrant Exercise Date” means the earliest to occur of
(i) the date on which the first Advance is made under the Loan Agreement, (ii) the Funding Termination Date (as defined in the Loan Agreement), (iii) immediately prior to the effective date of the Company’s initial registered
public offering of the Company’s securities, or (iv) immediately prior to any acquisition of the Company, whether by merger or consolidation, or through a transaction or series of transactions pursuant to which the holders of the
Company’s voting equity securities do not hold at least 50% of the voting power of the Company or any resulting entity after such transaction or transactions, or through the sale of all or substantially all of its assets. 

2. Term. The right to purchase Applicable Stock upon exercise hereof is exercisable at any time and from time to time from the
Warrant Exercise Date until the tenth anniversary of the Warrant Date; provided that, in the event that Agent and Lenders (as defined in the Loan Agreement) decline to provide the Company with the first Advance under the Loan Agreement in
circumstances where (A) Borrower has requested such Advance in accordance with the Loan Agreement, (B) Borrower has satisfied the conditions set forth in Article 3 of the Loan Agreement (other than Section 3.01(c)(iii)) and
(C) Agent and Lenders have determined that an event or condition exists that has had or could be reasonably expected to have a Material Adverse Effect (as defined in the Loan Agreement), then in such event, this Warrant shall immediately
terminate and be cancelled and of no further effect. 
 3. Payment and Exercise. 

(a) Methods of Exercise. The purchase right represented by this Warrant may be exercised by the Holder, in whole or in part and from
time to time, at the election of the Holder, by (a) the surrender of this Warrant (with the notice of exercise substantially in the form attached hereto as Exhibit A duly completed and executed) at the principal office of the Company and
by the payment to the Company, by check, or by wire transfer to an account designated by the Company of an amount equal to the then applicable Exercise Price multiplied by the number of Shares then being purchased (the “Aggregate Purchase
Price”); (b) if in connection with a registered public offering of the Company’s securities, to the extent permitted by the underwriter and the Company, the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit B duly completed and executed) at the principal office of the Company together with notice of arrangements reasonably satisfactory to the Company for payment to the Company from the proceeds of the sale of shares to be sold by
the Holder in such public offering of the Aggregate Purchase Price; or (c) exercise of the “net issuance” right provided for in Section 3(b) hereof. The person or persons in whose name(s) any certificate(s) representing Shares of
Applicable Stock shall be issuable upon exercise of this Warrant shall be deemed to have become the holder(s) of record of, and shall be treated for all purposes as the record holder(s) of, the Shares represented thereby (and such Shares shall be
deemed to have been issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any exercise of the rights represented by this Warrant, certificates for the Shares so purchased shall
be delivered to the Holder as soon as possible and in any event within thirty (30) days after such exercise and, unless this Warrant has been fully exercised or expired, a new Warrant representing the portion of the Shares, if any, with respect
to which this Warrant shall not then have been exercised shall also be issued to the Holder as soon as possible and in any event within such thirty-day period; provided, however, that at such time as the Company is subject to the reporting
requirements of the 

  
 -2- 

 
Securities Exchange Act of 1934, as amended, if requested by the Holder, the Company shall cause its transfer agent to deliver the certificate representing Shares issued upon exercise of
this Warrant to a broker or other person (as directed by the Holder exercising this Warrant) within the time period required to settle any trade made by the Holder after exercise of this Warrant. 

(b) Right to Convert Warrant into Stock: Net Issuance. 

(i) Net Issuance Right. In addition to and without limiting the rights of the Holder under the terms of this Warrant, the Holder shall
have the right to convert this Warrant or any portion thereof (the “Net Issuance Right”) into shares of Applicable Stock as provided in this Section 3(b) at any time or from time to time during the term of this Warrant.
Upon exercise of the Net Issuance Right with respect to a particular number of shares subject to this Warrant (the “Converted Warrant Shares”), the Company shall deliver to the Holder (without payment by the Holder of any
exercise price or any cash or other consideration) that number of shares of fully paid and nonassessable Applicable Stock as is determined according to the following formula: 
  

			
	X =	 	A - B
		 	   Y

  

					
	Where:	  	X =	  	the number of shares of Applicable Stock that shall be issued to Holder
			
		  	Y =	  	the fair market value of one share of Applicable Stock
			
		  	A =	  	the aggregate fair market value of the specified number of Converted Warrant Shares (i.e., the number of Converted Warrant Shares multiplied by the fair market value of one Converted Warrant Share)
			
		  	B =	  	the aggregate Exercise Price of the specified number of Converted Warrant Shares immediately prior to the exercise of the Net Issuance Right (i.e., the number of Converted Warrant Shares multiplied by the Exercise
Price)

 No fractional shares shall be issuable upon exercise of the Net Issuance Right, and, if the number of shares to be
issued determined in accordance with the foregoing formula is other than a whole number, the Company shall pay to the Holder an amount in cash equal to the fair market value of the resulting fractional share on the Conversion Date (as hereinafter
defined). For purposes of Section 10 of this Warrant, shares issued pursuant to the Net Issuance Right shall be treated as if they were issued upon the exercise of this Warrant. 

(ii) Exercise of Net Issuance Right. The Net Issuance Right may be exercised by the Holder by the surrender of this Warrant at the
principal office of the Company together with a written statement (which may be in the form of Exhibit A or Exhibit B hereto) specifying that the Holder thereby intends to exercise the Net Issuance Right and indicating the number of shares
subject to this Warrant which are being surrendered (referred to in Section 3(b)(i) hereof as the Converted Warrant Shares) in exercise of the Net Issuance Right. Such conversion shall be effective upon receipt by the Company of this Warrant
together with the aforesaid written statement, or on such later date as is specified therein (the “Conversion Date”), and, at the election of the Holder, may be made contingent upon the closing of the sale of the
Company’s Common Stock to the public in a public offering (a “Public Offering”) pursuant to a Registration Statement under the Securities Act of 1933, amended (the “Act”). Certificates for the
shares issuable upon exercise of the Net Issuance Right and, if applicable, a new warrant evidencing the balance of the shares remaining subject to this Warrant, shall be issued as of the Conversion Date and shall be delivered to the Holder within
thirty (30) days following the Conversion Date. 

  
 -3- 

 (iii) Determination of Fair Market Value. For purposes of this Section 3(b),
“fair market value” of a share of Applicable Stock as of a particular date (the “Determination Date”) shall mean: 

(1) If the Net Issuance Right is exercised in connection with and contingent upon a Public Offering, and if the Company’s Registration
Statement relating to such Public Offering (“Registration Statement”) has been declared effective by the Securities and Exchange Commission, then the initial “price to the public” specified in the final prospectus
with respect to such offering. 
 (2) If the Net Issuance Right is not exercised in connection with and contingent upon a Public Offering,
then as follows: 
 (A) If traded on a securities exchange, then the fair market value shall be the average of the closing
prices of the Common Stock on such exchange over the five trading days immediately prior to the Determination Date; 
 (B)
If traded on the Nasdaq Stock Market or other over-the-counter system, then the fair market value shall be the average of the closing bid prices of the Common Stock over the five trading days immediately prior to the Determination Date; and 

(C) If there is no public market, then fair market value shall be determined in good faith by the Company’s Board of
Directors. 
 In making a determination under clauses (A) or (B) above, if on the Determination Date, five trading days have not passed since the
Company’s initial Public Offering then the fair market value of the Common Stock shall be the average closing prices or closing bid prices, as applicable, for the shorter period beginning on and including the date of the initial Public Offering
and ending on the trading day prior to the Determination Date (or if such period includes only one trading day the closing price or closing bid price, as applicable, for such trading day). If closing prices or closing bid prices are no longer
reported by a securities exchange or other trading system, the closing price or closing bid price shall be that which is reported by such securities exchange or other trading system at 4:00 p.m. New York City time on the applicable trading day. 

(c) Exercise Prior to Expiration. To the extent this Warrant is not previously exercised as to all of the Shares subject hereto, and if
the fair market value of one share of the Applicable Stock is greater than the Exercise Price then in effect, this Warrant shall be deemed automatically exercised pursuant to Section 3(b) (even if not surrendered) immediately before its
expiration, including but not limited to expiration pursuant to Section 2. For purposes of such automatic exercise, the fair market value of one share of the Applicable Stock upon such expiration shall be determined pursuant to
Section 3(b)(iii). To the extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this Section 3(c), the Company agrees to promptly notify the Holder of the number of Shares, if any, the Holder is to
receive by reason of such automatic exercise. 
 4. Stock Fully Paid; Reservation of Shares. All Shares that may be issued upon the
exercise of the rights represented by this Warrant will, upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all preemptive rights and taxes, liens and charges with respect to the issuance
thereof. During the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights evidenced by this Warrant,
a sufficient number of shares of its Applicable Stock to provide for the exercise of the rights represented by this Warrant. 

  
 -4- 

 5. Adjustment of Exercise Price and Number of Shares. The number and kind of securities
purchasable upon the exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 

(a) Reclassification or Merger. In case of any reclassification or change of securities of the class issuable upon exercise of this
Warrant (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a subdivision or combination), or in case of any merger of the Company with or into another entity (other than a
merger with another entity in which the Company is the acquiring and the surviving entity and which does not result in any reclassification or change of outstanding securities issuable upon exercise of this Warrant), or in case of any sale of all or
substantially all of the assets of the Company, the Company, or such successor or purchasing corporation, as the case may be, shall duly execute and deliver to the Holder a new Warrant (in form and substance satisfactory to the Holder), or the
Company shall make appropriate provision without the issuance of a new Warrant, so that the Holder shall have the right to receive upon exercise of this Warrant, at a total purchase price not to exceed that payable upon the exercise of the
unexercised portion of this Warrant, and in lieu of the shares of Applicable Stock theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other securities, money and property receivable upon such
reclassification, change, merger or sale by a holder of the number of shares of Applicable Stock then purchasable under this Warrant. The provisions of this Section 5(a) shall similarly apply to successive reclassifications, changes, mergers
and sales. 
 (b) Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and
unexpired shall subdivide or combine its outstanding shares of Applicable Stock, the Exercise Price shall be proportionately decreased and the number of Shares issuable hereunder shall be proportionately increased in the case of a subdivision and
the Exercise Price shall be proportionately increased and the number of Shares issuable hereunder shall be proportionately decreased in the case of a combination. 

(c) Stock Dividends and Other Distributions. If the Company at any time while this Warrant is outstanding and unexpired shall
(i) pay a dividend with respect to Applicable Stock payable in Applicable Stock, then the Exercise Price shall be adjusted, from and after the date of determination of shareholders entitled to receive such dividend or distribution, to that
price determined by multiplying the Exercise Price in effect immediately prior to such date of determination by a fraction (A) the numerator of which shall be the total number of shares of Applicable Stock outstanding immediately prior to such
dividend or distribution, and (B) the denominator of which shall be the total number of shares of Applicable Stock outstanding immediately after such dividend or distribution; or (ii) make any other distribution with respect to Applicable
Stock (except any distribution specifically provided for in Sections 5(a) and 5(b)), then, in each such case, provision shall be made by the Company such that the Holder shall receive upon exercise of this Warrant a proportionate share of any
such dividend or distribution as though it were the holder of the Applicable Stock as of the record date fixed for the determination of the shareholders of the Company entitled to receive such dividend or distribution. 

(d) Adjustment of Number of Shares. Upon each adjustment in the Exercise Price, the number of Shares of Applicable Stock purchasable
hereunder shall be adjusted, to the nearest whole share, to the product obtained by multiplying the number of Shares purchasable immediately prior to such adjustment in the Exercise Price by a fraction, the numerator of which shall be the Exercise
Price immediately prior to such adjustment and the denominator of which shall be the Exercise Price immediately thereafter. 
 6. Notice
of Adjustments. Whenever the Exercise Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 5 hereof, the Company shall make a certificate signed by its chief financial officer setting forth, in
reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and the number of Shares purchasable hereunder after giving effect to such adjustment,
and shall cause copies of such certificate to be delivered to the Holder. 
 7. Fractional Shares. No fractional shares of Applicable
Stock will be issued in connection with any exercise hereunder, but in lieu of such fractional shares the Company shall make a cash payment therefor based on the fair market value of the Applicable Stock on the date of exercise as reasonably
determined in good faith by the Company’s Board of Directors. 

  
 -5- 

 8. Compliance with Act; Disposition of Warrant or Shares of Applicable Stock. 

(a) Compliance with Act. The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Applicable Stock to be issued
upon exercise hereof are being acquired for investment and that the Holder will not offer, sell or otherwise dispose of this Warrant, or any shares of Applicable Stock to be issued upon exercise hereof except under circumstances which will not
result in a violation of the Act or any applicable state securities laws. Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act and any applicable state securities laws or an exemption from such registration is
available, the Holder shall confirm in writing that the shares of Applicable Stock so purchased are being acquired for investment and not with a view toward distribution or resale in violation of the Act and shall confirm such other matters related
thereto as may be reasonably requested by the Company, including the Holder’s status as an “accredited investor” as such term is defined in Rule 501 of Regulations D promulgated under the Act. This Warrant and all shares of Applicable
Stock issued upon exercise of this Warrant (unless registered under the Act and any applicable state securities laws) shall be stamped or imprinted with a legend in substantially the following form: 

“THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR
DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT
OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 8 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED, DIRECTLY OR INDIRECTLY.” 

Said legend shall be removed by the Company, upon the request of the Holder, at such time as the restrictions on the transfer of the applicable security shall
have terminated. 
 (b) Disposition of Warrant or Shares. With respect to any offer, sale or other disposition of this Warrant or any
shares of Applicable Stock acquired pursuant to the exercise of this Warrant prior to registration of such Warrant or shares, the Holder agrees to give written notice to the Company prior thereto, describing briefly the manner thereof, together with
a written opinion of counsel, if requested by the Company, or other evidence, if reasonably satisfactory to the Company, to the effect that such offer, sale or other disposition may be effected without registration or qualification (under the Act as
then in effect or any federal or state securities law then in effect) of this Warrant or such shares of Applicable Stock and indicating whether or not under the Act certificates for this Warrant or such shares of Applicable Stock to be sold or
otherwise disposed of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such law. Upon receiving such written notice and reasonably satisfactory opinion of counsel or other evidence,
the Company, as promptly as practicable but no later than fifteen (15) days after receipt of the written notice, shall notify the Holder that the Holder may sell or otherwise dispose of this Warrant or such shares of Applicable Stock, all in
accordance with the terms of the notice delivered to the Company; provided, however, in any such transfer, if applicable, the transferee shall on the Company’s request agree in writing to be bound by the terms of this Warrant as if an original
holder hereof. If a determination has been made pursuant to this Section 8(b) that the opinion of counsel or other evidence is not reasonably satisfactory to the Company, the Company shall so notify the Holder promptly with details thereof
after such determination has been made. Notwithstanding the foregoing, this Warrant or such shares of Applicable Stock may, as to such federal laws, be offered, sold or otherwise disposed of in accordance with Rule 144 or 144A under the Act,
provided that the Company shall have been furnished with such information as the Company may reasonably request to provide a reasonable assurance that the provisions 

  
 -6- 

 
of Rule 144 or 144A have been satisfied. Each certificate representing this Warrant or the shares of Applicable Stock thus transferred (except a transfer pursuant to Rule 144 or 144A
after the expiration of applicable holding periods) shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the Holder, such legend is not
required in order to ensure compliance with such laws. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions. 

(c) Applicability of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of
Section 8(b) above shall apply to any transfer of, or grant of a security interest in, this Warrant (or the Applicable Stock or Common Stock obtainable upon exercise thereof) or any part hereof (i) to a partner of the Holder if the Holder
is a partnership or to a member of or other holder of an interest in the Holder if the Holder is a limited liability company, (ii) to a partnership of which the Holder is a partner or to a limited liability company of which the Holder is a
member or other holder of an interest, or (iii) to any affiliate of the Holder if the Holder is a corporation; provided, however, in any such transfer, if applicable, the transferee shall on the Company’s request agree in
writing to be bound by the terms of this Warrant as if an original holder hereof. 
 9. Rights as Shareholders; Information. No
Holder, as a holder of this Warrant, shall be entitled to vote or receive dividends or be deemed the holder of Applicable Stock or any other securities of the Company which may at any time be issuable upon the exercise hereof for any purpose, nor
shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a shareholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. Notwithstanding the foregoing,
the Company will transmit to the Holder such information, documents and reports as are generally distributed to the holders of any class or series of the securities of the Company concurrently with the distribution thereof to the shareholders. 

10. Stockholders Agreement. At such time that Holder exercises the Warrant, it agrees to become a party to that certain Amended and
Restated Stockholders’ Agreement dated as of June 30, 2010, as may be amended from time to time, and to execute a joinder agreement substantially in the form of Exhibit D of the Stockholders’ Agreement evidencing its joinder therein.

 11. Notice Rights. 

(a) Acquisition Transactions. The Company shall provide the Holder with at least ten (10) days’ written notice prior to
closing thereof of the terms and conditions of any of the following transactions (to the extent the Company has notice thereof): (i) the sale, lease, exchange, conveyance or other disposition of all or substantially all of the Company’s
property or business, or (ii) its merger into or consolidation with any other corporation (other than a wholly-owned subsidiary of the Company), or any transaction (including a merger or other reorganization) or series of related transactions,
in which more than 50% of the voting power of the Company is disposed of. 
 (b) Dividends and Repurchases. The Company shall provide
the Holder with at least ten (10) days notice prior to the record date of any cash dividend with respect to or offer to repurchase the Applicable Stock. 

(c) Liquidation. The Company shall provide the Holder with at least ten (10) days notice prior to any voluntary or involuntary
dissolutions, liquidation or winding-up of the Company. 

  
 -7- 

 12. Representations and Warranties. The Company represents and warrants to the Holder as
follows: 
 (a) This Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company
enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance, injunctive relief and other
equitable remedies. 
 (b) The Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with
the terms hereof, will be validly issued, fully paid and nonassessable and free from preemptive rights. 
 (c) The rights, preferences,
privileges and restrictions granted to or imposed upon the Applicable Stock and the holders thereof are as set forth in the Company’s Certificate of Incorporation, as amended through the Warrant Date, a true and complete copy of which is
attached hereto as Exhibit C (the “Charter”). 
 (d) As of the Warrant Date, the execution and delivery of this
Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms hereof would not be, inconsistent with the Company’s Charter or by-laws, do not and would not contravene any law, governmental rule or
regulation, judgment or order applicable to the Company, and do not and would not conflict with or contravene any provision of, or constitute a default under, any material indenture, material mortgage, material contract or other material instrument
of which the Company is a party or by which it is bound or require the consent or approval of, the giving of notice to, the registration or filing with or the taking of any action in respect of or by, any Federal, state or local government authority
or agency or other person, except for the filing of notices pursuant to federal and state securities laws, which filings will be effected by the time required thereby. 

(e) As of the Warrant Date, there are no actions, suits, audits, investigations or proceedings pending or, to the knowledge of the Company,
threatened against the Company in any court or before any governmental commission, board or authority which would have a material adverse effect on the ability of the Company to perform its obligations under this Warrant. 

(f) The number of shares of Common Stock of the Company outstanding on the Warrant Date and immediately preceding the closing of the Series C
Preferred financing, on a fully diluted basis (assuming the conversion of all outstanding convertible securities and the exercise of all outstanding options and warrants), does not exceed 135 million shares. 

13. Information Rights. The Company shall provide to the Holder the financial statements specified in this Section 13 prepared in
accordance with generally accepted accounting principles, consistently applied (except, in the case of unaudited financial statements, for the absence of footnotes and normal year-end adjustments); provided, however, that after the effective date of
the initial registration statement covering a public offering to the Company’s securities, the Company shall only be required to make available through the “Edgar” filing system those financial statements required to be filed by the
Securities and Exchange commission, to be made available as soon as practicable and no less frequently than quarterly. As soon as practicable (and in any event within 45 days after the end of each fiscal quarter, an unaudited balance sheet as of the
end of such fiscal quarter and unaudited statements of income or loss, retained earnings or deficit, cash flows and capital structure of the Company for such quarter, certified by the Company’s Chief Executive Officer or Chief Financial Officer
to fairly present in all material respects the data reflected therein. As soon as practicable (and in any event within 180 days after the end of each fiscal year, audited balance sheets as of the end of such year (consolidated if applicable) and
related statements of income or loss, retained earnings or deficit, cash flows and capital structure of the Company for such year, setting forth in comparative form the corresponding figures for the preceding fiscal year, and accompanied by an audit
report and unqualified (except with respect to a going concern qualification, if applicable) opinion of the independent certified public accountants of recognized national or regional standing selected by the Company. 

  
 -8- 

 14. Confidentiality. Except as otherwise required by applicable law, the Holder shall
maintain the confidentiality of all confidential or proprietary Company information acquired or to be acquired pursuant to this Warrant and shall not disclose or use such information other than in connection with its investment in the Company,
including any permitted disposition of this Warrant and any exercise of remedies under any loan arrangements in place between Holder or Holder’s affiliates and the Company, and not for any other purpose (including to disadvantage competitively
the Company or any other entity directly or indirectly controlled by or under common control with the Borrowers). The obligations of this Section 14 shall survive any termination or expiration of this Warrant. 

15. Modification and Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of the same is sought. 
 16. Notices. Any notice, request,
communication or other document required or permitted to be given or delivered to the Holder or the Company shall be delivered, or shall be sent by certified or registered mail, postage prepaid, nationally recognized overnight courier, by prepaid
facsimile or electronic mail (in each case upon customary confirmation of receipt), or delivered personally to the Holder at its address as shown on the books of the Company or to the Company at the address indicated therefor on the signature page
of this Warrant. 
 17. Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding the Company by
merger, consolidation or acquisition of all or substantially all of the Company’s assets, and all of the obligations of the Company relating to the Applicable Stock issuable upon the exercise or conversion of this Warrant shall survive the
exercise, conversion and termination of this Warrant and all of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the Holder. 

18. Lost Warrants or Stock Certificates. The Company covenants to the Holder that, upon receipt of evidence reasonably satisfactory to
the Company of the loss, theft, destruction or mutilation of this Warrant or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company, or in the case of any
such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company will make and deliver a new Warrant or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant or stock
certificate. 
 19. Descriptive Headings. The descriptive headings of the various Sections of this Warrant are inserted for
convenience only and do not constitute a part of this Warrant. The language in this Warrant shall be construed as to its fair meaning without regard to which party drafted this Warrant. 

20. Governing Law. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by,
the laws of the State of California. 
 21. Survival of Representations, Warranties and Agreements. All representations and
warranties of the Company and the Holder contained herein shall survive the Warrant Date, the exercise or conversion of this Warrant (or any part hereof) or the termination or expiration of rights hereunder, until any statute of limitations has run
after the termination or expiration of all rights hereunder. 
 22. Remedies. In case any one or more of the covenants and agreements
contained in this Warrant shall have been breached, the Holder (in the case of a breach by the Company), or the Company (in the case of a breach by the Holder), may proceed to protect and enforce their or its rights either by suit in equity and/or
by action at law, including, but not limited to, an action for damages as a result of any such breach and/or an action for specific performance of any such covenant or agreement contained in this Warrant. 

  
 -9- 

 23. No Impairment of Rights. The Company will not, by amendment of its Charter or through
any other means, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder against impairment. 
 24. Severability. The invalidity or unenforceability
of any provision of this Warrant in any jurisdiction shall not affect the validity or enforceability of such provision in any other jurisdiction, or affect any other provision of this Warrant, which shall remain in full force and effect. 

25. Recovery of Litigation Costs. If any legal action or other proceeding is brought for the enforcement of this Warrant, or because of
an alleged dispute, breach, default, or misrepresentation in connection with any of the provisions of this Warrant, the successful or prevailing party or parties shall be entitled to recover reasonable attorneys’ fees and other costs incurred
in that action or proceeding, in addition to any other relief to which it or they may be entitled. 
 26. Entire Agreement. This
Warrant constitutes the entire agreement between the parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations, and undertakings of the parties, whether oral or written, with
respect to such subject matter. 

  
 -10- 

 The Company and the Holder have caused this Warrant to be duly executed and delivered as of the
Warrant Date specified above. 
  

			
	TV2 HOLDING COMPANY
		
	By	 	  

		
	Title	 	  

  

			
	Address:	 	TV2 Holding Company
		 	3910 Brickway, Boulevard
		 	Santa Rosa, CA 95403

  

			
	[Entity Affiliated with Pinnacle Ventures]
	a Delaware limited liability company
		
	By:	 	  

	Name:	 	
	Title:	 	

 [Signature Page to Common Stock Warrant (PVII)] 

 EXHIBIT A 

NOTICE OF EXERCISE 
  

	To:	TV2 HOLDING COMPANY (the “Company”) 

 1. The undersigned hereby: 

 

	 	 ̈	elects to purchase                  shares of [Applicable Stock] [Common Stock] of the Company pursuant to the terms of the attached
Warrant, and tenders herewith payment of the purchase price of such shares in full, or 

  

	 	 ̈	elects to exercise its net issuance rights pursuant to Section 3(b) of the attached Warrant with respect to                  Shares of
[Applicable Stock] [Common Stock]. 

 2. Please issue a certificate or certificates representing
                 shares in the name of the undersigned or in such other name or names as are specified below: 

 

	
	  

(Name) 
  

	
	  

	
	  

(Address) 
 3. The undersigned
represents that the aforesaid shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of
distributing or reselling such shares, all except as in compliance with applicable securities laws. 
  

	
	  

	(Signature)

  

	
	  

	(Date)

 EXHIBIT B 

NOTICE OF EXERCISE 
  

	To:	TV2 HOLDING COMPANY (the “Company”) 

 1. Contingent upon and effective immediately
prior to the closing (the “Closing”) of the Company’s public offering contemplated by the Registration Statement on Form S    , filed             ,
20    , the undersigned hereby: 
  ̈ elects to purchase
                 shares of [Applicable Stock] [Common Stock] of the Company (or such lesser number of shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant, or 
  ̈ elects to exercise its net issuance
rights pursuant to Section 3(b) of the attached Warrant with respect to                  Shares of [Applicable Stock] [Common Stock]. 

2. Please deliver to the custodian for the selling shareholders a stock certificate representing such
                 shares. 
 3. The undersigned has
instructed the custodian for the selling shareholders to deliver to the Company $         or, if less, the net proceeds due the undersigned from the sale of shares in the aforesaid public offering. If such net
proceeds are less than the purchase price for such shares, the undersigned agrees to deliver the difference to the Company prior to the Closing pursuant to arrangements (such as escrow) to be reasonably agreed between the Company and the
undersigned. 
  

	
	  

	(Signature)

  

	
	  

	(Date)

 EXHIBIT C 

CHARTER

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]